Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pregnenolone is a naturally occurring endogenous neurosteroid synthesized from cholesterol in the adrenal glands and central nervous system. It serves as a precursor to various hormones, including glucocorticoids, mineralocorticoids, progestogens, androgens, estrogens, and other neuroactive steroids. It is available as an over-the-counter supplement and is being investigated for its potential therapeutic effects, including antidepressant, cognitive-enhancing, and neuroprotective properties. Its mechanism of action involves the positive modulation of NMDA receptors by its sulfated derivative and the enhancement of GABA(A) receptor signaling by its metabolite, allopregnanolone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pregnenolone.